# Safety and Efficacy Study of M2951 in Participants With Rheumatoid Arthritis

> **NCT02784106** · PHASE2 · COMPLETED · sponsor: **EMD Serono Research & Development Institute, Inc.** · enrollment: 65 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Placebo
- **DRUG:** M2951
- **DRUG:** M2951

## Key facts

- **NCT ID:** NCT02784106
- **Lead sponsor:** EMD Serono Research & Development Institute, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-31
- **Primary completion:** 2017-04-30
- **Final completion:** 2017-11-14
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2018-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02784106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02784106, "Safety and Efficacy Study of M2951 in Participants With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02784106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*